Back to Search
JOHN MERRILL, D.O.
D.O.
Family Medicine Physician
NPI: 1992152326Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
20A16056(CA)
Research & Publications (20)
In vitro and in vivo pharmacological models to assess demyelination and remyelination.
PMID 18800062·Neuropsychopharmacology·2009
6-review
Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
PMID 19169851·J Neurol·2009
7-preclinical
Substance abuse prevention infrastructure: a survey-based study of the organizational structure and function of the D.A.R.E. program.
PMID 16956400·Subst Abuse Treat Prev Policy·2006
8-other
Methadone medical maintenance in primary care. An implementation evaluation.
PMID 15857492·J Gen Intern Med·2005
4-observational
Providing care coordination and treatment services for substance-abusing women in the Work First/New Jersey (TANF) Program.
PMID 15201116·J Health Soc Policy·2004
8-other
Policy progress for physician treatment of opiate addiction.
PMID 12047733·J Gen Intern Med·2002
8-other
Treatment of drug dependence in the context of traditional disease treatment models.
PMID 12461229·Psychiatr Serv·2002
8-other
Mutual mistrust in the medical care of drug users: the keys to the "narc" cabinet.
PMID 12047728·J Gen Intern Med·2002
8-other
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus.
PMID 19359262·Ann Rheum Dis·2010
4-observational
Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease.
PMID 19547978·Rheumatol Int·2010
8-other
Opioid use behaviors, mental health and pain--development of a typology of chronic pain patients.
PMID 19473786·Drug Alcohol Depend·2009
8-other
Identification and characterization of kava-derived compounds mediating TNF-alpha suppression.
PMID 19538508·Chem Biol Drug Des·2009
7-preclinical
A polymorphism within IL21R confers risk for systemic lupus erythematosus.
PMID 19644854·Arthritis Rheum·2009
4-observational
Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing.
PMID 19387458·Genes Immun·2009
8-other
Identification of new SLE-associated genes with a two-step Bayesian study design.
PMID 19440200·Genes Immun·2009
8-other
New directions in the treatment of systemic lupus erythematosus.
PMID 19435401·Curr Med Res Opin·2009
6-review
Evaluation of C1q genomic region in minority racial groups of lupus.
PMID 19440201·Genes Immun·2009
8-other
Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders.
PMID 19581051·Pain·2009
8-other
Connective tissue diseases: What does the death of Riquent hold for the future of SLE?
PMID 19491911·Nat Rev Rheumatol·2009
8-other
Measurement of opioid problems among chronic pain patients in a general medical population.
PMID 19473787·Drug Alcohol Depend·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1119 HIGHLAND AVE, SUITE A
CLARKSTON, WA 99403 - Phone
- (509) 758-1450
Quick Facts
- NPI
- 1992152326
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile